IP Transactions: Peering Through the Looking-Glass Without Falling Down a Rabbit Hole 

Sponsored by: Foley Hoag LLP


Christine Bellon is the Chief Legal Officer for Beam Therapeutics.  Prior to joining Beam, she led legal groups at Forma Therapeutics, Relay Therapeutics, Blueprint Medicines, Hydra Biosciences and Infinity Pharmaceuticals.  Earlier in her career, she practiced law in the Boston office of Fish & Richardson P.C. Chris holds a B.S. in Chemistry from Yale University; a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology, where she did research in the laboratory of K. Barry Sharpless; and a J.D. from Columbia Law School.  She is a Trustee of the Boston Museum of Science and a member of the Boston Bar Association Council. 

Barbara Fiacco is a Partner, co-chair of the Intellectual Property Department and co-chair of the Patent, Trade Secrets, and Related Rights Litigation Practice at Foley Hoag LLP. In her practice, Barbara handles complex intellectual property and business disputes in the life sciences industry, involving therapeutic proteins and antibodies, gene therapy products, small molecule compounds, drug delivery systems, molecular diagnostics, epigenetic methods, single-cell sequencing technology, and medical devices.  She has successfully litigated patent, trade secret, and inventorship disputes for global pharmaceutical and biotechnology companies, medical device manufacturers and research institutions. Barbara is a Past President of the American Intellectual Property Association (AIPLA). She is recognized as a leading IP lawyer Chambers USA, IAM Patent 1000, Managing Intellectual Property’s IP Stars and Top 250 Women. She is a graduate of Dartmouth College and Harvard Law School.  

Jeremy McKown is the Global Patent Head of Johnson & Johnson’s pharmaceutical business, where he manages a global team of attorneys and professionals focused on creating robust patent portfolios and providing strategic counsel to its’ Innovative Medicine companies. In addition, he advises on R&D and IP transactions and litigations, and actively works with external trade associations to ensure and enhance meaningful IP policies.  Previously, he led the R&D Legal team responsible for drafting and negotiating complex agreements for the Innovative Medicine companies.  Prior to Johnson & Johnson, he worked as a Senior Counsel – Patents for Schering Plough, and in private practice in Washington, DC.   Jeremy has a B.S. in Chemistry from Ithaca College, a M.S. in Chemistry from Bucknell University and a J.D. from Syracuse University College of Law.

David Pauling presently serves as the General Counsel of Sutro Biopharma, Inc. He joined Sutro in 2011 and has since held positions of increasing responsibility, including Intellectual Property Counsel, Associate General and Senior Intellectual Property Counsel, and Executive Director of Legal Affairs. Prior to joining Sutro, Mr. Pauling practiced law at Jones Day and at Pennie & Edmonds, LLP. Mr. Pauling received his J.D. from Santa Clara University School of Law (magna cum laude), and an M.A. in Molecular Biology and a B.S. in Biochemistry and Molecular Biology from the University of California, Santa Cruz. 

Jeremy Younkin is a partner and co-chair of the Patent, Trade Secrets, and Related Rights litigation practice at Foley Hoag.  Jeremy handles patent infringement cases and other IP-related litigation, such as disputes over royalty payments and ownership of IP rights.  He has represented life sciences clients in significant IP disputes concerning biotherapeutics, recombinant DNA technology, and tools and methods for cellular analysis. He has also handled cases involving an array of subject matter outside the life sciences, from satellite dishes to cosmetic packaging. He is a graduate of Carleton College and Harvard Law School.